Roberto Luiz Kaiser

Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

Brian G. Feagan, Bruce E. Sands, William J. Sandborn et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 224 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +12

Risankizumab for Ulcerative Colitis

Edouard Louis, Stefan Schreiber, Remo Panaccione et al. · JAMA · 2024 · 110 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Is the Quality of Life Better in Patients with Colostomy than Patients with Fecal Incontience?

Patrick Colquhoun, Roberto Luiz Kaiser, Jonathan E. Efron et al. · World Journal of Surgery · 2006 · 70 citations

Medicine, Surgery, Gastroenterology +11

Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease

Milton Artur Ruiz, Roberto Luiz Kaiser, Luiz Gustavo de Quadros et al. · BMC Research Notes · 2017 · 32 citations · Full text

Medicine, Hematology, Immunology +16

Endoscopic Argon Plasma Coagulation vs. Multidisciplinary Evaluation in the Management of Weight Regain After Gastric Bypass Surgery: a Randomized Controlled Trial with SHAM Group

Luiz Gustavo de Quadros, Manoel Galvão Neto, João Caetano Marchesini et al. · Obesity Surgery · 2020 · 31 citations

Medicine, Perioperative Medicine, Surgery +10